Cargando…
The Tumorigenic Properties of EZH2 are Mediated by MiR-26a in Uveal Melanoma
Background: The polycomb group protein enhancer of zeste homolog 2 (EZH2) has been found to be highly expressed in various tumors, and microRNA-26a (miR-26a) is often unmodulated in cancers. However, the functions of these two molecules in uveal melanoma (UM) and their relationships have not been re...
Autores principales: | Li, Yao, Zhang, Mingmei, Feng, Huayin, Mahati, Shaya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350384/ https://www.ncbi.nlm.nih.gov/pubmed/34381816 http://dx.doi.org/10.3389/fmolb.2021.713542 |
Ejemplares similares
-
Delivery of miR-26a Using an Exosomes-Based Nanosystem Inhibited Proliferation of Hepatocellular Carcinoma
por: Mahati, Shaya, et al.
Publicado: (2021) -
Applying Single-Cell Technology in Uveal Melanomas: Current Trends and Perspectives for Improving Uveal Melanoma Metastasis Surveillance and Tumor Profiling
por: Wang, Mona Meng, et al.
Publicado: (2021) -
Co-administration of temozolomide (TMZ) and the experimental therapeutic targeting miR-10b, profoundly affects the tumorigenic phenotype of human glioblastoma cells
por: Chen, Ming, et al.
Publicado: (2023) -
lncRNAs-EZH2 interaction as promising therapeutic target in cutaneous melanoma
por: Wozniak, Michal, et al.
Publicado: (2023) -
Implication of miR-122, miR-483, and miR-335 Expression Levels as Potential Signatures in HCV-Related Hepatocellular Carcinoma (HCC) in Egyptian Patients
por: Elfert, Ashraf Y., et al.
Publicado: (2022)